|
Govt plans to launch dedicated portal to expand scope of HvPI
|
|
Shardul Nautiyal, Mumbai
August 28 , 2015
|
|
|
To help broaden the scope and reach of Haemovigilance Programme of India
(HvPI) in the country which was earlier limited to reporting adverse
transfusion reactions in blood recipients only, the government plans to
launch a website to get access to and connect with both blood donors and
recipients in a seamless manner.
According to official sources,
the HvPI website will become more broad-based with the launching of
National Blood Donor Vigilance Programme (NBDVP) recently to improve
donor safety and satisfaction through monitoring, analysing and
researching adverse events. NBDVP envisages to help analyse risk
factors, implement and evaluate preventive measures, reduce frequency of
adverse events and increase donor frequency.
Launched on
December 10, 2012 by National Institute of Biologicals (NIB), HvPI
currently generates reports on blood recipient related adverse reaction
through a TRRF. This is then linked via Haemovigil software to NIB.
In
a similar manner, NBDVP will collect blood donor data from blood banks
and medical institutions through a Blood Donor Adverse Reaction
Reporting Form (BDARF). This will help the authorities to come full
circle with respect to reporting adverse reactions both in terms of
blood donor and recipient and hence serve the larger purpose of blood
safety through HvPI.
NBDVP was launched in June this year on
World Blood Donor Day at Science City, Kolkata to improve donor safety
and satisfaction through monitoring, analysing and researching adverse
events. It will also help to analyse risk factors, implement and
evaluate preventive measures, reduce frequency of adverse events and
increase donor frequency.
A standard practice in many countries,
haemovigilance is aimed at keeping details pertaining to collection,
investigation, its analysis and transfusion of blood or blood
components. It also documents adverse reactions to recipients and the
people handling the vital fluid. NIB is an autonomous institution under
the Union health ministry which ensures quality of biologicals and
vaccines in the country available through domestic manufacturers or
imports.
HvPI, which was launched at the national level by NIB
aims to identify trends in adverse reactions and events, thereby to form
transfusion policy, target areas for improvement in practice, stimulate
research, raise awareness of transfusion hazards, give an early warning
of new complications to improve safety of transfusion for patients.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|